The allocation of vaccine funding varies depending on the phase and requirements of the vaccine development cycle:
Early-Stage Research: Funds are directed towards basic research, preclinical studies, and initial clinical trials. Clinical Trials: Significant funding is required for Phase I, II, and III clinical trials to evaluate safety and efficacy. Manufacturing and Scale-Up: Investments are needed to build manufacturing capabilities and ensure large-scale production. Distribution and Administration: Resources are allocated for the logistics of vaccine delivery and the implementation of immunization programs.
